home / stock / pasg / pasg quote
Last: | $0.916 |
---|---|
Change Percent: | -2.05% |
Open: | $0.91 |
Close: | $0.916 |
High: | $0.9379 |
Low: | $0.9 |
Volume: | 20,844 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.916 | $0.91 | $0.916 | $0.9379 | $0.9 | 20,844 | 07-05-2024 |
$0.8917 | $1.01 | $0.8917 | $1.02 | $0.8511 | 68,100 | 07-04-2024 |
$0.8917 | $1.01 | $0.8917 | $1.02 | $0.8511 | 68,100 | 07-03-2024 |
$0.9996 | $0.99 | $0.9996 | $1.03 | $0.99 | 160,810 | 07-02-2024 |
$0.885 | $0.81 | $0.885 | $0.93 | $0.79 | 317,551 | 07-01-2024 |
$0.7942 | $0.95 | $0.7942 | $0.95 | $0.7942 | 256,294 | 06-28-2024 |
$0.9239 | $0.92 | $0.9239 | $0.924 | $0.91 | 15,767 | 06-27-2024 |
$0.912 | $0.93 | $0.912 | $0.9599 | $0.89 | 37,038 | 06-26-2024 |
$0.912 | $0.93 | $0.912 | $0.9766 | $0.91 | 28,267 | 06-25-2024 |
$0.91 | $0.91 | $0.91 | $0.96 | $0.8882 | 46,561 | 06-24-2024 |
$0.91 | $0.93 | $0.91 | $0.96995 | $0.8801 | 186,175 | 06-21-2024 |
$0.93 | $0.9512 | $0.93 | $0.987 | $0.880101 | 71,724 | 06-20-2024 |
$0.955 | $1 | $0.955 | $1.02 | $0.91 | 115,105 | 06-19-2024 |
$0.955 | $1 | $0.955 | $1.02 | $0.91 | 115,105 | 06-18-2024 |
$1.01 | $1.05 | $1.01 | $1.09 | $1 | 32,082 | 06-17-2024 |
$1.05 | $1.07 | $1.05 | $1.09 | $1.01 | 38,000 | 06-14-2024 |
$1.07 | $1.04 | $1.07 | $1.0856 | $1.01 | 45,046 | 06-13-2024 |
$1.04 | $1.06 | $1.04 | $1.33 | $1 | 236,762 | 06-12-2024 |
$1.09 | $1.08 | $1.09 | $1.11 | $1.02 | 51,678 | 06-11-2024 |
$1.09 | $1.19 | $1.09 | $1.19 | $1.08 | 61,803 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
PHILADELPHIA, June 05, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that William Chou, M.D., president and chief executive officer, will present at ...
PHILADELPHIA, May 21, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced Carrie Gordon, a sophomore at Drexel University, as the third recipient of i...